Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt

BSE1260.75-57.5 (-4.36 %)

PREV CLOSE ( ) 1318.25

OPEN PRICE ( ) 1356.55

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 26439

TODAY'S LOW / HIGH ( )1255.00 1356.55

52 WK LOW / HIGH ( )489.2 1678.6

NSE1259.70-59.95 (-4.54 %)

PREV CLOSE( ) 1319.65

OPEN PRICE ( ) 1320.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1259.70 (620)

VOLUME 288743

TODAY'S LOW / HIGH( ) 1253.70 1349.00

52 WK LOW / HIGH ( )490.15 1679.9

Source Date	Board Meeting Date	Details
03-Feb-2025	07-Feb-2025	Quarterly Results
08-Nov-2024	13-Nov-2024	Quarterly Results
05-Aug-2024	09-Aug-2024	Quarterly Results
21-May-2024	28-May-2024	Audited Results
20-Mar-2024	26-Mar-2024	Inter alia, to consider and determine the issue price of Equity Shares to be issued pursuant to the Issue, including any discount, not more than 5%, on the floor price calculated in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (?SEBI ICDR Regulations?) and approved by the shareholders of the Company pursuant to a special resolution dated 14th August, 2023.
05-Feb-2024	14-Feb-2024	Quarterly Results
06-Nov-2023	14-Nov-2023	Quarterly Results
04-Aug-2023	14-Aug-2023	Quarterly Results
19-May-2023	26-May-2023	Audited Results
03-Feb-2023	13-Feb-2023	Quarterly Results
« ‹ 1 2 3 4 › »